Market Tracker

10/31 12:25pm ET
51.34
Real-Time Quote
 +0.05 / +0.10%
Today’s Change
34.28
Today|||52-Week Range
54.25
+26.27%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close51.29
Today’s open51.48
Day’s range51.09 - 52.50
Volume396,953
Average volume (3 months)866,873
Market cap$7.2B
Dividend yield--
Data as of 12:10pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.61%
Earnings growth (next 5 years)+11.88%
Revenue growth (last year)+47.59%
P/E ratio426.4
Price/Sales5.42
Price/Book6.97

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-1.14-0.80%
TAROTaro Pharmaceutical ...+1.45+0.92%
PBYIPuma Biotechnology I...-0.83-0.34%
UTHRUnited Therapeutics ...+2.07+1.59%
Data as of 12:22pm ET, 10/31/2014

Financials

Next reporting dateNovember 27, 2014
EPS forecast (this quarter)$0.02
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts